fda warning on semaglutide The has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and FDA alerts health care providers,

Storage Quick Reference Community sources commonly describe storing unopened vials frozen, with reconstitution limited to a 3-4 week supply

In this setting, all 93 patients had a recurrent and/or metastatic disease and were treated with at least two chemotherapy and/or radiotherapy lines and were not suitable for surgery or chemo/radiotherapy

Jadot G, Michelson AM, Puget K

Canada Health Canada does not list Epitalon as an approved natural health product or prescription medication

Genetic Testing and Personalized Semaglutide Therapy Before making any medication switch, consider whether your current treatment aligns with your genetic predispositions for GLP-1 response

More research is required around nutraceuticals to optimise their dosages